Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)

BACKGROUND: In recent years, genetic factors have attracted research interest as important predisposing factors for cardiovascular susceptibility. This study aimed to investigate the influences of dual-dose clopidogrel, clopidogrel combined with tongxinluo, and ticagrelor on the platelet activity an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuxia, Zhang, Yi, Wang, Lili, Geng, Yanping, Gu, Jian, Hao, Qingqing, Wang, Hua, Qi, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555704/
https://www.ncbi.nlm.nih.gov/pubmed/28783717
http://dx.doi.org/10.12659/MSM.903054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555704/
https://www.ncbi.nlm.nih.gov/pubmed/28783717
http://dx.doi.org/10.12659/MSM.903054

Ejemplares similares